British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017.

J Psychopharmacol 2017 05 25;31(5):519-552. Epub 2017 Apr 25.

12 South London and Maudsley NHS Foundation Trust, London, UK.

Decisions about the use of psychotropic medication in pregnancy are an ongoing challenge for clinicians and women with mental health problems, owing to the uncertainties around risks of the illness itself to mother and fetus/infant, effectiveness of medications in pregnancy and risks to the fetus/infant from in utero exposure or via breast milk. These consensus guidelines aim to provide pragmatic advice regarding these issues. They are divided into sections on risks of untreated illness in pregnancy; general principles of using drugs in the perinatal period; benefits and harms associated with individual drugs; and recommendations for the management of specific disorders.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0269881117699361DOI Listing
May 2017
37 Reads

Publication Analysis

Top Keywords

psychotropic medication
8
aim provide
4
uncertainties risks
4
risks illness
4
general principles
4
guidelines aim
4
illness mother
4
risks untreated
4
problems uncertainties
4
harms associated
4
women mental
4
mental health
4
provide pragmatic
4
benefits harms
4
health problems
4
mother fetus/infant
4
period benefits
4
principles drugs
4
fetus/infant utero
4
utero exposure
4

References

(Supplied by CrossRef)

Abel KM et al.
Psychopharmacology and pregnancy 2014

Bateman BT et al.
2016

Similar Publications